Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

by C. Peraldo-Neia, P. Ostano, G. Cavalloni, Y. Pignochino, D. Sangiolo, L. De Cecco, E. Marchesi, D. Ribero, A. Scarpa, A. M. De Rose, A. Giuliani, F. Calise, C. Raggi, P. Invernizzi, M. Aglietta, G. Chiorino, F. Leone
Published 2018-06-01

The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.

by S Di Matteo, L Nevi, D Costantini, D Overi, G Carpino, S Safarikia, F Giulitti, C Napoletano, E Manzi, A M De Rose, F Melandro, M Bragazzi, P B Berloco, F Giuliante, G Grazi, A Giorgi, V Cardinale, L Adorini, E Gaudio, D Alvaro
Published 2019-01-01